| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Medical Equipment/Supplies/Accessories
|
Compare with Industry peers |
| Website | http://www.gkb.net | |
| Market Cap | 57.62 Cr. | |
| Enterprise Value(EV) | 53.06 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -7.56 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 57.49 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 120.43 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 0.95 | Calculated using Price: 114.31 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.50 Cr. | 5,040,580 Shares |
| FaceValue | 10 | |
| About GKB Ophthalmics Ltd. | ||
| The Company is engaged in the business of manufacturing and supply of semi - finished plastic lenses. It has manufacturing facilities at Tivim Industrial Estate, Mapusa - Goa. | ||
| 1 Day |
|
+0.57% |
| 1 Week |
|
+25.15% |
| 1 Month |
|
+37.64% |
| 3 Month |
|
+18.70% |
| 6 Month |
|
+17.85% |
| 1 Year |
|
+10.23% |
| 2 Year |
|
+32.76% |
| 5 Year |
|
+15.52% |
| 10 Year |
|
+251.72% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | -3.3 | 9.32 | 5.65 | -2.12 | -2.52 | -4.41 | -1.23 | 3.09 | 0.18 | |
| Return on Capital Employed (%) | 0.82 | 18.94 | 7.99 | 0.25 | -0.34 | -1.38 | 1.48 | 4.58 | 2.44 | |
| Return on Assets (%) | -1.78 | 5.48 | 3.34 | -1.15 | -1.36 | -2.41 | -0.69 | 1.73 | 0.1 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 40 | 45 | 47 | 45 | 55 | 59 | 63 | 63 | 63 | 62 | |
| Non Curr. Liab. | 2 | 2 | 2 | 2 | 5 | 5 | 6 | 8 | 7 | 3 | |
| Curr. Liab. | 33 | 23 | 37 | 36 | 37 | 41 | 38 | 39 | 41 | 42 | |
| Minority Int. | 4 | 4 | 5 | 5 | |||||||
| Equity & Liab. | 75 | 69 | 86 | 83 | 97 | 106 | 111 | 114 | 116 | 113 | |
| Non Curr. Assets | 29 | 18 | 19 | 19 | 33 | 33 | 37 | 38 | 32 | 28 | |
| Curr. Assets | 46 | 51 | 66 | 64 | 64 | 73 | 74 | 76 | 84 | 85 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 75 | 69 | 86 | 83 | 97 | 106 | 111 | 114 | 116 | 113 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 35 | 44 | 74 | 77 | 57 | 59 | 57 | 71 | 75 | 87 | |
| Other Income | 1 | 2 | 1 | 0 | 2 | 1 | 2 | 1 | 1 | 1 | |
| Total Income | 36 | 46 | 75 | 78 | 59 | 59 | 59 | 72 | 76 | 88 | |
| Total Expenditure | -34 | -46 | -72 | -76 | -56 | -56 | -55 | -66 | -72 | -86 | |
| PBIDT | 1 | 0 | 3 | 2 | 3 | 3 | 4 | 6 | 5 | 1 | |
| Interest | -3 | -2 | -1 | -1 | -1 | -1 | -2 | -1 | -2 | -2 | |
| Depreciation | -2 | -1 | -1 | -2 | -4 | -4 | -3 | -3 | -3 | -4 | |
| Taxation | 1 | -4 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Exceptional Items | 1 | 11 | 3 | -1 | |||||||
| PAT | -1 | 4 | 3 | -1 | -1 | -2 | -1 | 2 | 0 | -4 | |
| Minority Interest | 0 | -1 | 0 | 0 | |||||||
| Share Associate | 1 | 0 | 1 | 0 | |||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 4 | 3 | -1 | -1 | -2 | -1 | 1 | 0 | -4 | ||
| Adjusted EPS | 0 | 10 | 6 | -2 | -2 | -4 | -2 | 3 | 0 | -8 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 6 | 7 | -11 | -3 | -3 | 4 | 3 | 7 | 5 | -3 | |
| Cash Fr. Inv. | -2 | -1 | 15 | 4 | 1 | -10 | -4 | -17 | -4 | 1 | |
| Cash Fr. Finan. | -5 | -6 | -3 | -1 | 1 | 13 | 4 | 3 | -2 | -2 | |
| Net Change | 0 | 1 | 0 | -1 | 0 | 7 | 4 | -7 | 0 | -4 | |
| Cash & Cash Eqvt | 2 | 3 | 3 | 2 | 2 | 9 | 13 | 6 | 6 | 2 |
|
Thu, 25 Apr 2024
Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2024. GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31 2024.The notice can be accessed at the Companys website at www.gkb.netFurther notice is hereby given with reference to the above meeting of the Board of Directors that the trading window for dealing with equity shares of the company by designated persons under SEBI (Prohibition of Insider Trading) Regulation 2015 had been closed from April 01 2024 will now re-open on Monday June 03 2024. |
|
Thu, 18 Apr 2024
Compliance Certificate Under Regulation 40(9)& 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 For The Year Ended March 31 2024. Pursuant to Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 please find enclosed and Compliance Certificate issued by Practicing Company Secretary for the year ended March 31 2024.Please acknowledge receipt. |
|
Thu, 11 Apr 2024
Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018. Pursuant to Circular no. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018 issued by the Securities and Exchange Board of India we hereby confirm that GKB Ophthalmics Limited is not a "Large Corporate" as defined in the said Circular and hence the said Circular is not applicable to us.Kindly take the above information on record. |
| Thu, 25 Apr 2024 |
High Delivery Percentage
|
Opening at High
|
Close Within 52 Week High Zone
|
Opening at High for 2 Days
|
High Increase in 1 Month
|
